Details of the Drug

General Information of Drug (ID: DMORMM8)

Drug Name
Tetrazolast meglumine
Synonyms Tetrazolast; Tetrazolast meglumine salt monohydrate; MDL-26024; MDL-26024GO
Indication
Disease Entry ICD 11 Status REF
Asthma CA23 Discontinued in Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C17H25N9O6
Canonical SMILES
CNCC(C(C(C(CO)O)O)O)O.C1=CC=C2C(=C1)C=C(C3=NN=NN23)C4=NNN=N4.O
InChI
InChI=1S/C10H6N8.C7H17NO5.H2O/c1-2-4-8-6(3-1)5-7(9-11-14-15-12-9)10-13-16-17-18(8)10;1-8-2-4(10)6(12)7(13)5(11)3-9;/h1-5H,(H,11,12,14,15);4-13H,2-3H2,1H3;1H2/t;4-,5+,6+,7+;/m.0./s1
InChIKey
PXORXOKNKGCVHI-BMWGJIJESA-N
Cross-matching ID
PubChem CID
9825038
CAS Number
133008-33-0
TTD ID
D03PHU

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001730)